Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Adam M. Hutt’s Leviticus Partners Reported 8.1% Passive Stake in $LTRX

Adam M. Hutt’s Leviticus Partners amended its passive stake in Lantronix Inc. (LTRX) to 8.1%, according to the firm’s SEC filing on November 10th. Leviticus Partners now has 800 thousand shares in LTRX. This is the second amend 13G that the firm filed for its LTRX position. Leviticus Partners previously filed 991 thousand shares, or 9.6% stake in LTRX on December 8th, 2010; and 684 thousand shares or 6.6% stake on May 13th, 2010. However, Leviticus Partners’ LTRX position in the second quarter is unclear. LTRX is now trading at $1.38, near its 2-year low. The stock has lost 63% in 2011.


Jim Simons’ Renaissance Technologies was bullish about LTRX in the second quarter. The firm reported 78 thousand shares in the stock, up by 5% from Q1.

Leviticus Partners, L.P. is a private investment limited partnership managed by Adam M. Hutt. The firm aims to beat the S&P 500, the Russell 2000, and other common investment vehicles. The firm makes investments when the target company’s stock does not reflect its growth prospects and trades at a discount to its intrinsic value. The firm reduces downside risk while keeping upside participation via this approach.

According to Yahoo! Finance, Lantronix, Inc. “designs, develops, markets, and sells networking and Internet connectivity products that are used to access, manage, control, and configure electronic products over the Internet, enterprise, and other networks worldwide.” The company provides device enablement solutions, device management solutions, and legacy products. The company “serves healthcare, security, industrial and building automation, energy, information technology and data centers, transportation, and government markets. It sells its products through distributors, manufacturers representatives, value added resellers, and other resellers. The company was founded in 1989 and is headquartered in Irvine, California.”

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!